@fquedeville @gouvernementFR @EmmanuelMacron Réf 2019 ... https://t.co/LquDfCI5Kt Si les immunoglobulines mono ou polyclonales avaient eu, depuis 2019, un quelconque effet sur la mortalité les viroses (syncytiales) ... ça se saurait, n'est-ce pas Mme @Lac
@WHOWPRO https://t.co/vOr81V8dG9 Drug treatment for respiratory syncytial virus lung infections
Traitement médicamenteux des infections pulmonaires par le virus respiratoire syncytial https://t.co/uLSzbuWkw1
RT @RSVnews: Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection. https://t.co/…
Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection. https://t.co/4RGeZn80q9 #RSV
Traitement médicamenteux des infections pulmonaires par le virus respiratoire syncytial https://t.co/uLSzbuWkw1
RT @Cochrane_Child: Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection https:/…
RT @Cochrane_Child: Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection https:/…
RT @Cochrane_Child: Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection https:/…
Even for a fairly common pediatric topic, the evidence for effectiveness is low certainty for the IVIG treatment for hospitalised infants and young children w respiratory syncytial virus infection. https://t.co/mhDJBGW8J8
A new study is out in the Cochrane Database of Systematic Reviews called "Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection." You can request this article through your library resources. https
RT @CochraneLibrary: Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection https:…
Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection https://t.co/KEt6YphEAF New Systematic Review from @CochraneARI Includes 7 trials with 486 infants & children. #RSV
RT @Cochrane_Child: Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection https:/…
RT @Cochrane_Child: Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection https:/…
Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection https://t.co/McxfiI1KYi New Systematic Review from @CochraneARI #rsv Includes 7 trials with 486 infants & children. #childhealth https://t.c
RT @Wiley_Health: Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection. New Syst…
Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection. New Systematic Review from @CochraneARI #rsv Includes 7 trials with 486 infants & children. https://t.co/s857e7QPdJ https://t.co/k9PvDeG5BD
RT @CochraneUK: Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection: https://t.…
Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection - Sanders, SL - 2019 | Cochrane Library https://t.co/6aO5rStugm
RT @CochraneLibrary: Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection https:…
RT @CochraneLibrary: Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection https:…
RT @CochraneLibrary: Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection https:…
RT @CochraneLibrary: Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection https:…
Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection https://t.co/KEt6YphEAF New Systematic Review from @CochraneARI #rsv Includes 7 trials with 486 infants & children.
🔬 Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection. 📝 Cochrane Database Syst Rev. 👨🏻🔬 Sanders SL, et al. 🌎 https://t.co/m0eriMxZ99 #science #research https://t.co/opWmA6Won7
New #CochraneEvidence found insufficient evidence of differences between immunoglobulins & placebo for treating RSV‐proven lower respiratory tract infections in hospitalised children aged up to 3 years in terms of death, time in hospital, & adverse
🔬 Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection. 📝 Cochrane Database Syst Rev. 👨🏻🔬 Sanders SL, et al. 🌎 https://t.co/m0eriMxZ99 #science #research https://t.co/3rKDvGbD4z
This Cochrane review inc. studies on RSV-Ig, Palivizumab & Motavizumab- no beneficial effects vs placebo for treatment of acute #RSV What about normal IVIG? Immunoglobulin treatment for hosp infants & young children w/ #RespiratorySyncytialVirus in
Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection. https://t.co/4RGeZn80q9 #RSV